Voyager Therapeutics Total Assets 2014-2021 | VYGR

Voyager Therapeutics total assets from 2014 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Voyager Therapeutics Annual Total Assets
(Millions of US $)
2020 $262
2019 $355
2018 $177
2017 $184
2016 $190
2015 $229
2014 $11
2013 $0
Voyager Therapeutics Quarterly Total Assets
(Millions of US $)
2021-09-30 $185
2021-06-30 $209
2021-03-31 $238
2020-12-31 $262
2020-09-30 $270
2020-06-30 $297
2020-03-31 $323
2019-12-31 $355
2019-09-30 $376
2019-06-30 $389
2019-03-31 $411
2018-12-31 $177
2018-09-30 $197
2018-06-30 $215
2018-03-31 $235
2017-12-31 $184
2017-09-30 $141
2017-06-30 $158
2017-03-31 $175
2016-12-31 $190
2016-09-30 $202
2016-06-30 $210
2016-03-31 $220
2015-12-31 $229
2015-09-30 $166
2015-06-30 $0
2015-03-31 $0
2014-12-31 $11
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.112B $0.171B
Voyager Therapeutics, Inc. is a gene therapy company. It focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. Its pipeline includes VY-AADC01, which is in Phase 1b clinical trials for treatment of Parkinson's disease and preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis, VY-FXN01 for Friedreich ataxia and VY-HTT01 for Huntington's disease as well as VY-SMN101 for neuromuscular disease. Voyager Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $144.122B 9.11
Bio-Rad Laboratories (BIO.B) United States $18.677B 37.90
QIAGEN (QGEN) Netherlands $11.053B 18.72
Biohaven Pharmaceutical Holding (BHVN) United States $8.002B 0.00
Emergent Biosolutions (EBS) United States $2.809B 10.10
Arcus Biosciences (RCUS) United States $2.516B 0.00
Myovant Sciences (MYOV) United Kingdom $1.432B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.186B 0.00
Zymeworks (ZYME) Canada $0.697B 0.00
Ambrx Biopharma (AMAM) United States $0.230B 0.00
SQZ Biotechnologies (SQZ) United States $0.229B 0.00
Enzo Biochem (ENZ) United States $0.160B 20.69